Physician profile
Nilay Mehta
NPI 1225295132
$7,920.49
in general payments reported to CMS, 2019-2025
47 companies · $1,179 in 2025
The $1,179 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,082 · 2020: $799 · 2021: $1,174 · 2022: $894 · 2023: $1,254 · 2024: $1,537 · 2025: $1,179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,971.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,970.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $1,593.44 | 2019-2025 | Biomonitor, Amvia Edge, Acticor 7 Vr-T Dx |
| Abbott Laboratories | $1,359.48 | 2019-2025 | Aveir, Cardiomems, Assurity |
| Boston Scientific Corporation | $1,073.94 | 2019-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor, Watchman Access System |
| Medtronic, INC. | $521.98 | 2021-2025 | Interstim, Inceptiv |
| Novartis Pharmaceuticals Corporation | $501.10 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $335.51 | 2019-2024 | Xarelto |
| Impulse Dynamics (USA) INC. | $266.55 | 2024 | Optimizer |
| Pfizer INC. | $219.27 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $174.55 | 2019-2024 | |
| Imperative Care, INC | $161.38 | 2025 | Symphony Catheter |
| Abiomed | $152.86 | 2022-2025 | Impella |
| Amgen INC. | $148.54 | 2019-2023 | Repatha |
| Johnson & Johnson Surgical Vision, INC. | $145.02 | 2023 | Tecnis Iol |
| Janssen Scientific Affairs, LLC | $143.93 | 2025 | Tremfya |
| Sumitomo Pharma America, INC. | $106.73 | 2023-2025 | Gemtesa |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $93.05 | 2024 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.17 | 2022-2025 | Jardiance, Tradjenta, Synjardy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $81.53 | 2023-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $63.02 | 2022-2025 | Wainua, Lokelma |
| Esperion Therapeutics, INC. | $62.17 | 2021-2023 | Nexletol |
| Agiliti Surgical, INC. | $61.13 | 2024 | Soltive Superpulsed Laser, Koelis Trinity Fusion Biopsy System, Sonablate Hifu |
| Scpharmaceuticals INC. | $49.03 | 2025 | |
| Abbvie INC. | $47.18 | 2022-2024 | |
| Bard Peripheral Vascular, INC. | $33.94 | 2020 | |
| Csl Behring | $32.01 | 2025 | Haegarda |
| Tolmar, INC. | $30.97 | 2025 | Jatenzo, Eligard |
| Novo Nordisk INC | $30.00 | 2019-2023 | Wegovy |
| Glaxosmithkline, LLC. | $28.97 | 2019 | |
| Lilly USA, LLC | $28.21 | 2022-2023 | Jardiance |
| Laborie Medical Technologies Corp. | $27.06 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| E.R. Squibb & Sons, L.L.C. | $25.21 | 2024 | Eliquis |
| Regeneron Healthcare Solutions, INC. | $22.71 | 2019 | |
| 180 Medical, INC. | $21.49 | 2023 | |
| Shockwave Medical, INC | $21.41 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Olympus America INC. | $20.44 | 2024 | Itind System |
| Argon Medical Devices, INC. | $20.11 | 2023 | Tips |
| Merck Sharp & Dohme LLC | $19.26 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $19.21 | 2023 | Arcalyst |
| Corcept Therapeutics | $18.22 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $17.22 | 2023 | Inpefa |
| Astellas Pharma US INC | $16.78 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.55 | 2019 | |
| Medtronic Vascular, INC. | $14.06 | 2019 | |
| Cequr Corporation | $12.10 | 2023 | Cequr Simplicity |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nilay Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.